Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. (Q54192847)

26 May 2018

title

Evidence that anti-HBc but not HBV DNA testing may prevent some HBV transmission by transfusion. (English)

1 reference

26 May 2018

author name string

Allain JP

1

1 reference

26 May 2018

Hewitt PE

2

1 reference

26 May 2018

Tedder RS

3

1 reference

26 May 2018

Williamson LM

4

1 reference

26 May 2018

language of work or name

English

0 references

publication date

1 October 1999

1 reference

26 May 2018

British Journal of Haematology

published in

1 reference

26 May 2018

volume

107

1 reference

26 May 2018

issue

1

1 reference

26 May 2018

page(s)

186-195

1 reference

26 May 2018

Significance of antibody to hepatitis B core antigen in blood donors as determined by their serologic response to hepatitis B vaccine.

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Post-transfusion hepatitis: impact of non-A, non-B hepatitis surrogate tests. Canadian Post-Transfusion Hepatitis Prevention Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Mini-pool screening by nucleic acid testing for hepatitis B virus, hepatitis C virus, and HIV: preliminary results

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Serum hepatitis B virus DNA in acute hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Transmission of hepatitis B virus to multiple patients from a surgeon without evidence of inadequate infection control

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Hepatitis B virus surface mutations associated with infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Antibody to hepatitis B core antigen as a paradoxical marker for non-A, non-B hepatitis agents in donated blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Posttransfusion hepatitis B transmitted by blood from a hepatitis B surface antigen-negative hepatitis B virus carrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Donor screening for antibody to hepatitis B core antigen and hepatitis B virus infection in transfusion recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Feasibility and efficacy of routine PCR screening of blood donations for hepatitis C virus, hepatitis B virus, and HIV-1 in a blood-bank setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Absence of hepatitis B virus DNA detected by polymerase chain reaction in blood donors who are hepatitis B surface antigen negative and antibody to hepatitis B core antigen positive from a United States population with a low prevalence of hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

Food and Drug Administration conference on the feasibility of genetic technology to close the HIV window in donor screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.1999.01665.X

10.1046/J.1365-2141.1999.01665.X

21 January 2018

Identifiers

DOI

1 reference

26 May 2018

PubMed ID

10520040

1 reference

26 May 2018